Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Seoul, 05505, Republic of Korea.
Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Eur J Clin Microbiol Infect Dis. 2020 Nov;39(11):2133-2141. doi: 10.1007/s10096-020-03975-9. Epub 2020 Jul 6.
Data regarding extraintestinal Clostridioides difficile infections (ECDIs) remain scarce and anecdotal. We conducted a retrospective cohort study to investigate characteristics and prognostic factors in patients with ECDI. From January 1997 through December 2018, 60 patients were enrolled and divided into three groups as follows: group A (gastrointestinal [GI] disruption caused by malignancy, n = 13); group B (GI disruption from causes other than malignancy, n = 25); group C (no GI disruption, n = 22). GI disruption was defined as compromised integrity of the GI tract caused by abdominal surgery, perforation, malignancy, enterocolitis, or bleeding. The incidence of ECDI was 2.53 per 100,000 admissions. The most common specimens yielded C. difficile were blood (36.7%), peritoneal fluid (20.0%), and abscesses (16.7%). Six patients (10.0%) had confirmed C. difficile enterocolitis, and 36 patients (60.0%) had a polymicrobial infection. C. difficile bacteremia was significantly more common in group A patients than those in groups B or C (53.8% vs. 48.0% vs. 13.6%, p = 0.02), as was the 30-day mortality rate (69.2% vs. 12.0% vs. 18.2%, respectively; p < 0.001). In multivariate analysis, group A (adjusted odds ratio [aOR], 17.32; 95% confidence interval [CI], 2.96-101.21; p = 0.002) and an age of > 65 years (aOR, 7.09; 95% CI, 1.31-38.45; p = 0.02) were independent risk factors for 30-day mortality. ECDI was uncommonly associated with C. difficile enterocolitis. Two factors, GI disruption caused by malignancy, and old age, were associated with significantly poorer short-term outcomes.
有关肠道外艰难梭菌感染(ECDIs)的数据仍然很少且为传闻。我们进行了一项回顾性队列研究,以调查 ECDI 患者的特征和预后因素。从 1997 年 1 月至 2018 年 12 月,共纳入 60 名患者,并分为三组:A 组(由恶性肿瘤引起的胃肠道[GI]障碍,n=13);B 组(由恶性肿瘤以外的原因引起的 GI 障碍,n=25);C 组(无 GI 障碍,n=22)。GI 障碍定义为腹部手术、穿孔、恶性肿瘤、结肠炎或出血导致的胃肠道完整性受损。ECDIs 的发生率为每 100,000 例住院患者中有 2.53 例。最常检出艰难梭菌的标本为血液(36.7%)、腹腔液(20.0%)和脓肿(16.7%)。6 名患者(10.0%)确诊为艰难梭菌结肠炎,36 名患者(60.0%)存在混合感染。与 B 组或 C 组相比,A 组患者的艰难梭菌菌血症更为常见(53.8%比 48.0%比 13.6%,p=0.02),30 天死亡率也更高(分别为 69.2%、12.0%和 18.2%;p<0.001)。多变量分析显示,A 组(调整优势比[aOR],17.32;95%置信区间[CI],2.96-101.21;p=0.002)和年龄>65 岁(aOR,7.09;95%CI,1.31-38.45;p=0.02)是 30 天死亡率的独立危险因素。ECDIs 与艰难梭菌结肠炎不常见相关。GI 障碍由恶性肿瘤引起和年龄较大是与短期预后显著较差相关的两个因素。